Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Diet-driven microbial ecology underpins associations between cancer immunotherapy outcomes and the gut microbiome
Rebecca Simpson, Erin R. Shanahan, Marcel Batten, et al.
Nature Medicine (2022) Vol. 28, Iss. 11, pp. 2344-2352
Closed Access | Times Cited: 137

Showing 1-25 of 137 citing articles:

Gut microbiota in colorectal cancer development and therapy
Chi Chun Wong, Jun Yu
Nature Reviews Clinical Oncology (2023) Vol. 20, Iss. 7, pp. 429-452
Closed Access | Times Cited: 260
Fecal microbiota transplantation plus anti-PD-1 immunotherapy in advanced melanoma: a phase I trial
Bertrand Routy, John Lenehan, Wilson H. Miller, et al.
Nature Medicine (2023) Vol. 29, Iss. 8, pp. 2121-2132
Closed Access | Times Cited: 196
Dietary fiber and SCFAs in the regulation of mucosal immunity
Jian Tan, Laurence Macia, Charles R. Mackay
Journal of Allergy and Clinical Immunology (2022) Vol. 151, Iss. 2, pp. 361-370
Closed Access | Times Cited: 156
Embracing cancer complexity: Hallmarks of systemic disease
Charles Swanton, Elsa Bernard, Chris Abbosh, et al.
Cell (2024) Vol. 187, Iss. 7, pp. 1589-1616
Open Access | Times Cited: 140
An integrated tumor, immune and microbiome atlas of colon cancer
Jessica Roelands, Peter J.K. Kuppen, Eiman I. Ahmed, et al.
Nature Medicine (2023) Vol. 29, Iss. 5, pp. 1273-1286
Open Access | Times Cited: 93
Drug-microbiota interactions: an emerging priority for precision medicine
Qing Zhao, Yao Chen, Weihua Huang, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 73
Current advance of nanotechnology in diagnosis and treatment for malignant tumors
Bilan Wang, Shiqi Hu, Yan Teng, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 71
Gut OncoMicrobiome Signatures (GOMS) as next-generation biomarkers for cancer immunotherapy
Andrew Maltez Thomas, Marine Fidelle, Bertrand Routy, et al.
Nature Reviews Clinical Oncology (2023) Vol. 20, Iss. 9, pp. 583-603
Closed Access | Times Cited: 65
Effects of dietary intervention on human diseases: molecular mechanisms and therapeutic potential
Yu-Ling Xiao, Yue Gong, Ying-Jia Qi, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 56
Towards modulating the gut microbiota to enhance the efficacy of immune-checkpoint inhibitors
Rebecca Simpson, Erin R. Shanahan, Richard A. Scolyer, et al.
Nature Reviews Clinical Oncology (2023) Vol. 20, Iss. 10, pp. 697-715
Closed Access | Times Cited: 53
Corticosteroids and Cancer Immunotherapy
Rachel Goodman, Douglas B. Johnson, Justin M. Balko
Clinical Cancer Research (2023) Vol. 29, Iss. 14, pp. 2580-2587
Closed Access | Times Cited: 49
Association of a Mediterranean Diet With Outcomes for Patients Treated With Immune Checkpoint Blockade for Advanced Melanoma
Laura A. Bolte, Karla A. Lee, Johannes R. Björk, et al.
JAMA Oncology (2023) Vol. 9, Iss. 5, pp. 705-705
Open Access | Times Cited: 44
Longitudinal gut microbiome changes in immune checkpoint blockade-treated advanced melanoma
Johannes R. Björk, Laura A. Bolte, Andrew Maltez Thomas, et al.
Nature Medicine (2024) Vol. 30, Iss. 3, pp. 785-796
Open Access | Times Cited: 44
Neoadjuvant Checkpoint Immunotherapy and Melanoma: The Time Is Now
Georgina V. Long, Alexander M. Menzies, Richard A. Scolyer
Journal of Clinical Oncology (2023) Vol. 41, Iss. 17, pp. 3236-3248
Closed Access | Times Cited: 41
Role of the microbiota in response to and recovery from cancer therapy
Stephen J. Blake, Yochai Wolf, Ben Boursi, et al.
Nature reviews. Immunology (2023) Vol. 24, Iss. 5, pp. 308-325
Closed Access | Times Cited: 41
Nutritional regulation of microbiota-derived metabolites: Implications for immunity and inflammation
Mohammad Arifuzzaman, Nicholas Collins, Chun‐Jun Guo, et al.
Immunity (2024) Vol. 57, Iss. 1, pp. 14-27
Open Access | Times Cited: 37
Modulating gut microbiome in cancer immunotherapy: Harnessing microbes to enhance treatment efficacy
Xing Kang, Harry Cheuk-Hay Lau, Jun Yu
Cell Reports Medicine (2024) Vol. 5, Iss. 4, pp. 101478-101478
Open Access | Times Cited: 36
Microbiota-dependent activation of CD4 + T cells induces CTLA-4 blockade–associated colitis via Fcγ receptors
Bernard C. Lo, Ilona Kryczek, Jiali Yu, et al.
Science (2024) Vol. 383, Iss. 6678, pp. 62-70
Closed Access | Times Cited: 32
A gut microbial signature for combination immune checkpoint blockade across cancer types
Ashray Gunjur, Yan Shao, Timothy Rozday, et al.
Nature Medicine (2024) Vol. 30, Iss. 3, pp. 797-809
Open Access | Times Cited: 29
Randomized Placebo-Controlled, Biomarker-Stratified Phase Ib Microbiome Modulation in Melanoma: Impact of Antibiotic Preconditioning on Microbiome and Immunity
Isabella C. Glitza, Yongwoo David Seo, Christine N. Spencer, et al.
Cancer Discovery (2024) Vol. 14, Iss. 7, pp. 1161-1175
Open Access | Times Cited: 18
Gut microbiome affects the response to immunotherapy in non‐small cell lung cancer
Shengnan Ren, Lingxin Feng, Haoran Liu, et al.
Thoracic Cancer (2024) Vol. 15, Iss. 14, pp. 1149-1163
Open Access | Times Cited: 17
Fecal microbiota transplantation: no longer cinderella in tumour immunotherapy
Yunwei Yang, Yaping An, Yue Dong, et al.
EBioMedicine (2024) Vol. 100, pp. 104967-104967
Open Access | Times Cited: 16
Overcoming immunotherapy resistance in gastric cancer: insights into mechanisms and emerging strategies
D.Y. Luo, Jing Zhou, Shuiliang Ruan, et al.
Cell Death and Disease (2025) Vol. 16, Iss. 1
Open Access | Times Cited: 1
Gut microbiota-derived hexa-acylated lipopolysaccharides enhance cancer immunotherapy responses
Puspendu Sardar, Benjamin S. Beresford-Jones, Wangmingyu Xia, et al.
Nature Microbiology (2025) Vol. 10, Iss. 3, pp. 795-807
Open Access | Times Cited: 1
Bodywide ecological interventions on cancer
Guido Kroemer, Jennifer L. McQuade, Miriam Mérad, et al.
Nature Medicine (2023) Vol. 29, Iss. 1, pp. 59-74
Closed Access | Times Cited: 33
Page 1 - Next Page

Scroll to top